system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: METHOD, RESULTS. Meshes: Adolescent, Botulinum Toxins, Type A, Cerebral Palsy, Child, Child, Preschool, Female, Humans, Infant, Male, Neuromuscular Agents, Quality of Life, Severity of Illness Index, Surveys and Questionnaires.
user
Quality of life of children with cerebral palsy treated with botulinum toxin: are well-being measures appropriate? Context: Two QOL evaluation tools, translated into Portuguese, were used: Pediatric Outcomes Data Collection Instrument (PODCI) and Child's Caregiver Questionnaire (CCQ). Questionnaires were answered by caregivers on two occasions. Patients were divided into 3 groups: I--patients who had been previously treated with BTXA and who underwent a session of BTXA; II--patients who used BTXA for the first time; III--patients previously treated with BTXA but did not in this interval. Sixty-eight patients were evaluated. In group I (n=26) the functional ability had improvement for all types of CP (p=0.04), and tetraplegic increased interaction/communication (p=0.02). In group II (n=14) positioning improved (p=0.02). Group III (n=28) showed no change in QOL.
assistant
PODCI and CCQ are able to capture outcome in children with CP.